一、中文部分
吳信宏(2019),失智症照護在台灣的重要性,品質月刊,55(7),4-7。
林克能、劉秀枝(2003),臨床失智評量表,Acta Neurologica Taiwanica,12(3),154-165。
林佳靜、陳建勳(2022),應用資料探勘探討共同基金績效之持續性與從眾行為。管理資訊計算,11(1),216-228。
林雅嫻、林哲瑋、王文甫、王釧如、張凱茗、張倩蜜、葉瓊鈺、康宜靜、陳富滿、呂郁蕙、吳信宏(2020),女性阿茲海默症病人之照護目標組合的研究:以中部某醫學中心為例,品質學報,26(6),351-377。
邱逸榛、何玉婷、陳婉庭、徐亞瑛(2004),簡介阿茲海默氏症與其照護,長期照護雜誌,7(4),289-304。
侯東旭、周琬禎、林素鉁(2018),使用模糊 Apriori 演算法於數值型資料關聯規則探勘之研究-以糖尿病資料為例,醫療資訊雜誌,27(3),25-48。
梁家欣、程蘊菁、陳人豪(2014),失智症之重點回顧,內科學誌,25(3),151-157。
梁煙純(2004),我國多重慢性病患盛行率及醫療利用分析,國立陽明大學醫務管理研究所碩士論文。陳玟均、陳富滿、王文甫、王釧如、呂郁蕙、張凱茗、張倩蜜、葉瓊鈺、林哲瑋、康宜靜、吳信宏(2019),利用Apriori演算法探討失智症患者於照護者壓力之影響:以中部醫學中心為例,品質學報,26(6),395-418。
陳柏琪、許聖民、林幸君、陳肇男、張靜貞(2020),臺灣縣市別長照需求之中長期推計及趨勢分析,人文及社會科學集刊,32(4),523-558。
陳韋良、張耀文、高東煒(2017),失智症之診斷與治療,源遠護理,11(2),12-17。
廖述賢、溫志皓(2019),資料探勘:人工智慧與機器學習發展以SPSS Modeler為範例,新北市:博碩文化。
羅翊邦(2017),評值以病人為中心有氧運動訓練對多重慢性病中老年人身體活動量、體適能、生活品質及生理行為指標之成效:隨機對照試驗,國立國防醫學院護理研究所碩士論文。二、英文部分
Agrawal, R., Imilienski, T., & Swami, A. (1993). Mining association rules between sets of items in large databases. Proceedings of the ACM SIGMOD International Conference on the Management of Data, 207-216.
Anderson, G. F. (2010). Chronic care: making the case for ongoing care. Robert Wood Johnson Foundation.
Atella, V., Mortari, A. P., Kopinska, J., Belotti, F., Lapi, F., Cricelli, C., & Fontana, L. (2019). Trends in age-related disease burden and healthcare utilization. Aging Cell, 18(1), e12861.
Biessels, G. J., & Despa, F. (2018). Cognitive decline and dementia in diabetes mellitus: mechanisms and clinical implications. Nature Reviews Endocrinology, 14(10), 591-604.
Boyd, C. M., & Fortin, M. (2010). Future of multimorbidity research: how should understanding of multimorbidity inform health system design?. Public Health Reviews, 32(2), 451-474.
Brandlmeier, P. (1976). Multimorbidity among elderly patients in an urban general practice. Zeitschrift fur Allgemeinmedizin, 52(25), 1269-1275.
Bucki, A., Marcinkowska, M., Śniecikowska, J., Zagórska, A., Jamrozik, M., Pawłowski, M., Głuch-Lutwin, M., Siwek, A., Jakubczyk, M., Pytka, K., Jastrzębska-Więsek, M., Partyka, A., Wesołowska, A., Mierzejewski, P., & Kołaczkowski, M. (2020). Multifunctional 6-fluoro-3-[3-(pyrrolidin-1-yl)propyl]-1,2-benzoxazoles targeting behavioral and psychological symptoms of dementia (BPSD). European Journal of Medicinal Chemistry, 191, 112149.
Bugnicourt, J. M., Godefroy, O., Chillon, J. M., Choukroun, G., & Massy, Z. A. (2013). Cognitive disorders and dementia in CKD: the neglected kidney-brain axis. Journal of the American Society of Nephrology, 24(3), 353-363.
Bunn, F., Burn, A. M., Goodman, C., Rait, G., Norton, S., Robinson, L., Schoeman, J., & Brayne, C. (2014). Comorbidity and dementia: a scoping review of the literature. BMC Medicine, 12(1), 1-15.
Cerejeira, J., Lagarto, L., & Mukaetova-Ladinska, E. B. (2012). Behavioral and psychological symptoms of dementia. Frontiers in Neurology, 3, 73.
Chae, Y.M., Kim, H.S., Tark, K.C., Park, H.J., & Ho, S.H. (2003). Analysis of healthcare quality indicator using data mining and decision support system. Expert Systems with Applications, 24(2), 167-172.
Chireh, B., & D’Arcy, C. (2020). Contrasting trends in prevalence of chronic diseases and multimorbidity, Canada 1978–2014. SN Comprehensive Clinical Medicine, 2(9), 1563-1572.
Chang, C. C., Wang, W. F., Li, Y. Y., Chen, Y. A., Chen, Y. J., Liao, Y. C., Jhang, K. M., & Wu, H. H. (2021). Using the Apriori Algorithm to Explore Caregivers’ Depression by the Combination of the Patients with Dementia and Their Caregivers. Risk Management and Healthcare Policy, 14, 2953-2963.
Deckers, K., Schievink, S. H., Rodriquez, M. M., van Oostenbrugge, R. J., van Boxtel, M. P., Verhey, F. R., & Köhler, S. (2017). Coronary heart disease and risk for cognitive impairment or dementia: systematic review and meta-analysis. Plos One, 12(9), e0184244.
Fazio, S., Pace, D., Flinner, J., & Kallmyer, B. (2018). The fundamentals of person-centered care for individuals with dementia. The Gerontologist, 58(suppl_1), S10-S19.
Feinstein, A. R. (1970). The pre-therapeutic classification of co-morbidity in chronic disease. Journal of Chronic Diseases, 23(7), 455-468.
Garfinkel, D., Ilhan, B., & Bahat, G. (2015). Routine deprescribing of chronic medications to combat polypharmacy. Therapeutic Advances in Drug Safety, 6(6), 212-233.
Gupta, M., Singh, R., Singh, K., & Lehl, S. S. (2013). Reversible dementia and gait disturbance as a result of polypharmacy. Case Reports, 2013, bcr2013008932.
Han, J., & Kamber, M. (2006). Data Mining: Concepts and Techniques, 2nd Edition, Morgan Kaufmann Publishers, San Francisco.
Hopman, P., Schellevis, F. G., & Rijken, M. (2016). Health-related needs of people with multiple chronic diseases: differences and underlying factors. Quality of Life Research, 25(3), 651-660.
Ishikawa, H., & Yano, E. (2008). Patient health literacy and participation in the health-care process. Health Expectations, 11(2), 113-122.
Jennings, L. A., Palimaru, A., Corona, M. G., Cagigas, X. E., Ramirez, K. D., Zhao, T., Hays, R. D., Wenger, N. S., & Reuben, D. B. (2017). Patient and caregiver goals for dementia care. Quality of Life Research, 26(3), 685-693.
Jhang, K. M., Chang, M. C., Lo, T. Y., Lin, C. W., Wang, W. F., & Wu, H. H. (2019). Using the apriori algorithm to classify the care needs of patients with different types of dementia. Patient preference and adherence, 13, 1899–1912.
Johnston, M. C., Crilly, M., Black, C., Prescott, G. J., & Mercer, S. W. (2019). Defining and measuring multimorbidity: a systematic review of systematic reviews. European Journal of Public Health, 29(1), 182-189.
Kingston, A., Comas-Herrera, A., & Jagger, C. (2018). Forecasting the care needs of the older population in England over the next 20 years: estimates from the population ageing and care simulation (PACSim) modelling study. The Lancet Public Health, 3(9), e447-e455.
Lai, S. W., Lin, C. H., Liao, K. F., Su, L. T., Sung, F. C., & Lin, C. C. (2012). Association between polypharmacy and dementia in older people: a population-based case-control study in Taiwan. Geriatrics & Gerontology International, 12(3), 491-498.
Lau, D. T., Mercaldo, N. D., Harris, A. T., Trittschuh, E., Shega, J., & Weintraub, S. (2010). Polypharmacy and potentially inappropriate medication use among community-dwelling elders with dementia. Alzheimer Disease and Associated Disorders, 24(1), 56-63.
Marengoni, A., & Onder, G. (2015). Guidelines, polypharmacy, and drug-drug interactions in patients with multimorbidity. BMJ, 350, h1059.
Miranda, A. S., Cordeiro, T. M., dos Santos Lacerda Soares, T. M., Ferreira, R. N., & Simoes e Silva, A. C. (2017). Kidney-brain axis inflammatory cross-talk: from bench to bedside. Clinical Science, 131(11), 1093-1105.
Namara, K. M., Alzubaidi, H., & Jackson, J. K. (2019). Cardiovascular disease as a leading cause of death: how are pharmacists getting involved?. Integrated Pharmacy Research & Practice, 8, 1-11.
Park, H. Y., Park, J. W., Song, H. J., Sohn, H. S., & Kwon, J. W. (2017). The association between polypharmacy and dementia: a nested case-control study based on a 12-year longitudinal cohort database in South Korea. Plos One, 12(1), e0169463.
PhridviRaj, M. S. B., & GuruRao, C. V. (2014). Data mining–past, present and future–a typical survey on data streams. Procedia Technology, 12, 255-263.
Shabir, O., Moll, T. A., Matuszyk, M. M., Eyre, B., Dake, M. D., Berwick, J., & Francis, S. E. (2020). Preclinical models of disease and multimorbidity with focus upon cardiovascular disease and dementia. Mechanisms of Ageing and Development, 192, 111361.
Sprangers, M. A., de Regt, E. B., Andries, F., van Agt, H. M., Bijl, R. V., de Boer, J. B., Foets, M., Hoeymans, N., Jacobs, A. E., Kempen, G. I., Miedema, H. S., Tijhuis, M. A., & de Haes, H. C. (2000). Which chronic conditions are associated with better or poorer quality of life?. Journal of Clinical Epidemiology, 53(9), 895-907.
Willadsen, T. G., Bebe, A., Køster-Rasmussen, R., Jarbøl, D. E., Guassora, A. D., Waldorff, F. B., Reventlow, S., & Olivarius, N. (2016). The role of diseases, risk factors and symptoms in the definition of multimorbidity - a systematic review. Scandinavian Journal of Primary Health Care, 34(2), 112–121.
World Health Organization. (2004). The World health report: 2004: changing history. World Health Organization.
World Health Organization. (2008). The world health report 2008: primary health care now more than ever. World Health Organization.
Wu, C. Y., Ouk, M., Wong, Y. Y., Anita, N. Z., Edwards, J. D., Yang, P., Shah, B. R., Herrmann, N., Lanctôt, K. L., Kapral, M. K., MacIntosh, B. J., Rabin, J. S., Black, S. E., & Swardfager, W. (2020). Relationships between memory decline and the use of metformin or DPP4 inhibitors in people with type 2 diabetes with normal cognition or Alzheimer's disease, and the role APOE carrier status. Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 16(12), 1663–1673.
Yan, G.J., Wang, W.F., Jhang, KM., Lin, C.W., & Wu, H.H. (2019). Association between patients with dementia and high caregiving burden for caregivers from a medical center in Taiwan. Psychology Research and Behavior Management, 12, 55-65.
三、網路資源
Alzheimer’s Disease International (2019), World Alzheimer Report 2019 Attitudes to dementia, https://www.alzint.org/u/WorldAlzheimerReport2019-Summary.pdf。
台灣失智症協會(2021),失智人口知多少,2021年4月, http://www.tada2002.org.tw/About/IsntDementia#bn1。
行政院主計總處(2021),國情統計通報(第037號),2021年3月2日,https://www.stat.gov.tw/public/Data/132162358VPAVQ8D.pdf。
衛生福利部國民健康署(2021),民國106年國民健康訪問調查,2021年1月29日,https://www.hpa.gov.tw/Pages/Detail.aspx?nodeid=364&pid=13636。